Nutex Health (NASDAQ:NUTX) Given New $333.00 Price Target at Lake Street Capital

Nutex Health (NASDAQ:NUTX) had its target price lifted by equities research analysts at Lake Street Capital from $310.00 to $333.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Lake Street Capital‘s price target points to a potential upside of 71.51% from the stock’s current price.

Several other research analysts have also recently commented on the stock. B. Riley Financial raised their target price on shares of Nutex Health from $325.00 to $357.00 and gave the stock a “buy” rating in a report on Monday. LADENBURG THALM/SH SH started coverage on shares of Nutex Health in a research report on Monday, October 26th. They issued a “buy” rating and a $336.00 price target for the company. Zacks Research cut Nutex Health from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. Weiss Ratings raised Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, October 6th. Finally, Wall Street Zen lowered Nutex Health from a “buy” rating to a “hold” rating in a research note on Saturday, October 31st. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $342.00.

Nutex Health Stock Performance

NASDAQ:NUTX traded up $13.60 during mid-day trading on Monday, reaching $194.16. 153,906 shares of the company’s stock were exchanged, compared to its average volume of 167,001. Nutex Health has a one year low of $83.99 and a one year high of $226.16. The firm has a market capitalization of $1.33 billion, a PE ratio of 8.29 and a beta of 0.66. The business’s fifty day simple moving average is $203.11 and its two-hundred day simple moving average is $151.38. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 5.00.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings data on Thursday, November 5th. The company reported $5.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.54 by $0.17. The firm had revenue of $217.61 million during the quarter, compared to the consensus estimate of $214.82 million. Nutex Health had a net margin of 20.68% and a return on equity of 35.99%. Analysts anticipate that Nutex Health will post 26.65 earnings per share for the current fiscal year.

Insider Transactions at Nutex Health

In other Nutex Health news, Director Scott Saunders sold 203 shares of the business’s stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the completion of the transaction, the director directly owned 400 shares in the company, valued at $85,700. The trade was a 33.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 44.68% of the stock is owned by company insiders.

Institutional Investors Weigh In On Nutex Health

Large investors have recently modified their holdings of the business. BlackRock Inc. acquired a new position in shares of Nutex Health during the 2nd quarter worth $69,612,000. Winmill & CO. Inc. bought a new stake in shares of Nutex Health during the 2nd quarter worth $11,168,000. Empowered Funds LLC bought a new stake in shares of Nutex Health during the 2nd quarter worth $7,720,000. Bank of New York Mellon Corp acquired a new stake in Nutex Health in the second quarter valued at about $3,956,000. Finally, Bridge City Capital LLC acquired a new stake in Nutex Health in the third quarter valued at about $3,918,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.